These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11556750)
1. 34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast. Papotti M; Sapino A; Righi L; Chiappone S; Bussolati G Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):229-33. PubMed ID: 11556750 [TBL] [Abstract][Full Text] [Related]
2. 34betaE12 Cytokeratin Immunodetection in the Differential Diagnosis of Small Cell Tumors of Lung. Viberti L; Bongiovanni M; Croce S; Bussolati G Int J Surg Pathol; 2000 Oct; 8(4):317-322. PubMed ID: 11494008 [TBL] [Abstract][Full Text] [Related]
3. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations. Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Tumors of the Breast. Visscher DW; Yasir S Endocr Pathol; 2017 Jun; 28(2):121-127. PubMed ID: 28389994 [TBL] [Abstract][Full Text] [Related]
6. INSM1 Expression in Breast Neoplasms with Neuroedocrine Features. Metovic J; Castellano I; Marinelli E; Osella-Abate S; Sapino A; Cassoni P; Papotti M Endocr Pathol; 2021 Dec; 32(4):452-460. PubMed ID: 34008122 [TBL] [Abstract][Full Text] [Related]
7. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Tan A; Etit D; Bayol U; Altinel D; Tan S Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633 [TBL] [Abstract][Full Text] [Related]
8. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Lantuejoul S; Moro D; Michalides RJ; Brambilla C; Brambilla E Am J Surg Pathol; 1998 Oct; 22(10):1267-76. PubMed ID: 9777989 [TBL] [Abstract][Full Text] [Related]
9. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937 [TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related]
11. Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors. Khoor A; Stahlman MT; Johnson JM; Olson SJ; Whitsett JA Hum Pathol; 2004 May; 35(5):560-4. PubMed ID: 15138929 [TBL] [Abstract][Full Text] [Related]
12. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193 [TBL] [Abstract][Full Text] [Related]
13. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358 [TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Tumors of the Breast. Rosen LE; Gattuso P Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast. Sapino A; Papotti M; Pietribiasi F; Bussolati G Virchows Arch; 1998 Sep; 433(3):217-22. PubMed ID: 9769124 [TBL] [Abstract][Full Text] [Related]
16. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716 [TBL] [Abstract][Full Text] [Related]
17. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites. Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast. Tan BY; Thike AA; Ellis IO; Tan PH Am J Surg Pathol; 2016 Oct; 40(10):1334-42. PubMed ID: 27438988 [TBL] [Abstract][Full Text] [Related]
19. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Sturm N; Lantuéjoul S; Laverrière MH; Papotti M; Brichon PY; Brambilla C; Brambilla E Hum Pathol; 2001 Sep; 32(9):918-25. PubMed ID: 11567220 [TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Chan JK; Suster S; Wenig BM; Tsang WY; Chan JB; Lau AL Am J Surg Pathol; 1997 Feb; 21(2):226-34. PubMed ID: 9042291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]